Commentary: The American Red Cross reported that the national blood supply was down 35% — partly the result of extreme winter ...

His neck and underarms were swollen. His skin itched, particularly on his arms. Sleeping at night was impossible.

Beijing-based pharma, BeiGene’s Brukinsa (zanubrutinib) has been approved by the US Food and Drug Administration (FDA) for chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). CLL ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

NCCN now recommends pemivibart pre-exposure prophylaxis for patients with B-cell lymphomas and other profoundly ...

June 11, 2024 If national guidelines are revised to incorporate a new risk equation, about 40% fewer people could meet criteria for cholesterol-lowering statins to ... Study Estimates That Between ...

癌症日益加重的全球疾病负担亟需创新性治疗策略。细胞治疗作为肿瘤学领域的重大突破，正从嵌合抗原受体T（CAR-T）细胞在血液系统恶性肿瘤中的成功应用，迅速演进为多种策略并行发展的多平台格局。当前研究聚焦于T细胞受体工程化T（TCR-T）细胞、肿瘤浸润淋巴细胞（T 癌症日益加重的全球疾病负担亟需创新性治疗策略。细胞治疗作为肿瘤学领域的重大突破，正从嵌合抗原受体T（CAR-T）细胞在血液系统恶性肿瘤中的 ...